PIK3CA and non-small cell lung carcinoma: We also found that SOX2 gene gain is associated with copy number gains of other actionable oncogenes, including FGFR1 and PIK3CA. Our findings confirm the complexity of NSCLC biology and encourage the exploration of novel therapeutic combinations.